Annual Net Income
$4.86 B
-$6.97 B-58.91%
31 December 2023
Summary:
AbbVie annual net profit is currently $4.86 billion, with the most recent change of -$6.97 billion (-58.91%) on 31 December 2023. During the last 3 years, it has risen by +$247.00 million (+5.35%). ABBV annual net income is now -58.91% below its all-time high of $11.84 billion, reached on 31 December 2022.ABBV Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$1.56 B
+$191.00 M+13.94%
30 September 2024
Summary:
AbbVie quarterly net profit is currently $1.56 billion, with the most recent change of +$191.00 million (+13.94%) on 30 September 2024. Over the past year, it has dropped by -$217.00 million (-12.20%). ABBV quarterly net income is now -65.23% below its all-time high of $4.49 billion, reached on 31 March 2022.ABBV Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$5.12 B
-$217.00 M-4.06%
30 September 2024
Summary:
AbbVie TTM net profit is currently $5.12 billion, with the most recent change of -$217.00 million (-4.06%) on 30 September 2024. Over the past year, it has dropped by -$1.39 billion (-21.37%). ABBV TTM net income is now -61.80% below its all-time high of $13.41 billion, reached on 30 September 2022.ABBV TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABBV Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.9% | -12.2% | -21.4% |
| 3 y3 years | +5.3% | -50.9% | -32.0% |
| 5 y5 years | -14.5% | -17.1% | +57.4% |
ABBV Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -58.9% | +5.3% | -65.2% | +553.1% | -61.8% | +5.3% |
| 5 y | 5 years | -58.9% | +5.3% | -65.2% | +311.5% | -61.8% | +57.4% |
| alltime | all time | -58.9% | +174.1% | -65.2% | +185.5% | -61.8% | +608.2% |
AbbVie Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.56 B(+13.9%) | $5.12 B(-4.1%) |
| June 2024 | - | $1.37 B(+0.1%) | $5.34 B(-10.9%) |
| Mar 2024 | - | $1.37 B(+66.5%) | $5.99 B(+23.2%) |
| Dec 2023 | $4.86 B(-58.9%) | $822.00 M(-53.8%) | $4.86 B(-25.3%) |
| Sept 2023 | - | $1.78 B(-12.2%) | $6.51 B(-25.0%) |
| June 2023 | - | $2.02 B(+746.9%) | $8.69 B(+14.5%) |
| Mar 2023 | - | $239.00 M(-90.3%) | $7.58 B(-35.9%) |
| Dec 2022 | $11.84 B(+2.5%) | $2.47 B(-37.4%) | $11.84 B(-11.7%) |
| Sept 2022 | - | $3.95 B(+327.4%) | $13.41 B(+6.1%) |
| June 2022 | - | $924.00 M(-79.4%) | $12.64 B(+1.3%) |
| Mar 2022 | - | $4.49 B(+11.0%) | $12.48 B(+8.1%) |
| Dec 2021 | $11.54 B(+150.0%) | $4.04 B(+27.2%) | $11.54 B(+53.2%) |
| Sept 2021 | - | $3.18 B(+315.0%) | $7.53 B(+13.1%) |
| June 2021 | - | $766.00 M(-78.4%) | $6.66 B(+29.2%) |
| Mar 2021 | - | $3.55 B(+9769.4%) | $5.16 B(+11.8%) |
| Dec 2020 | $4.62 B(-41.4%) | $36.00 M(-98.4%) | $4.62 B(-37.5%) |
| Sept 2020 | - | $2.31 B(-412.7%) | $7.38 B(+6.1%) |
| June 2020 | - | -$738.00 M(-124.5%) | $6.96 B(-17.5%) |
| Mar 2020 | - | $3.01 B(+7.5%) | $8.44 B(+7.0%) |
| Dec 2019 | $7.88 B(+38.6%) | $2.80 B(+48.7%) | $7.88 B(+142.2%) |
| Sept 2019 | - | $1.88 B(+154.3%) | $3.25 B(-21.0%) |
| June 2019 | - | $741.00 M(-69.8%) | $4.12 B(-23.2%) |
| Mar 2019 | - | $2.46 B(-234.5%) | $5.36 B(-5.7%) |
| Dec 2018 | $5.69 B(+7.1%) | -$1.83 B(-166.5%) | $5.69 B(-24.8%) |
| Sept 2018 | - | $2.75 B(+38.5%) | $7.57 B(+17.3%) |
| June 2018 | - | $1.98 B(-28.7%) | $6.45 B(+1.1%) |
| Mar 2018 | - | $2.78 B(+5251.9%) | $6.38 B(+20.2%) |
| Dec 2017 | $5.31 B | $52.00 M(-96.8%) | $5.31 B(-20.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $1.63 B(-14.8%) | $6.65 B(+0.5%) |
| June 2017 | - | $1.92 B(+11.9%) | $6.62 B(+4.8%) |
| Mar 2017 | - | $1.71 B(+23.0%) | $6.31 B(+6.0%) |
| Dec 2016 | $5.95 B(+15.7%) | $1.39 B(-13.0%) | $5.95 B(-2.1%) |
| Sept 2016 | - | $1.60 B(-0.7%) | $6.08 B(+6.3%) |
| June 2016 | - | $1.61 B(+18.9%) | $5.72 B(+4.5%) |
| Mar 2016 | - | $1.35 B(-10.7%) | $5.48 B(+6.5%) |
| Dec 2015 | $5.14 B(+190.0%) | $1.52 B(+22.4%) | $5.14 B(+82.6%) |
| Sept 2015 | - | $1.24 B(-9.3%) | $2.82 B(+35.2%) |
| June 2015 | - | $1.37 B(+33.7%) | $2.08 B(+14.8%) |
| Mar 2015 | - | $1.02 B(-226.2%) | $1.82 B(+2.4%) |
| Dec 2014 | $1.77 B(-57.0%) | -$810.00 M(-260.1%) | $1.77 B(-52.2%) |
| Sept 2014 | - | $506.00 M(-53.9%) | $3.71 B(-11.0%) |
| June 2014 | - | $1.10 B(+12.0%) | $4.17 B(+0.7%) |
| Mar 2014 | - | $980.00 M(-13.1%) | $4.14 B(+0.3%) |
| Dec 2013 | $4.13 B(-21.7%) | $1.13 B(+17.0%) | $4.13 B(-9.1%) |
| Sept 2013 | - | $964.00 M(-9.7%) | $4.54 B(-12.0%) |
| June 2013 | - | $1.07 B(+10.3%) | $5.16 B(-3.7%) |
| Mar 2013 | - | $968.00 M(-37.1%) | $5.36 B(+1.6%) |
| Dec 2012 | $5.28 B(+53.7%) | $1.54 B(-2.8%) | $5.28 B(+7.8%) |
| Sept 2012 | - | $1.58 B(+25.1%) | $4.89 B(+47.4%) |
| June 2012 | - | $1.27 B(+43.5%) | $3.32 B(-7.6%) |
| Mar 2012 | - | $883.00 M(-23.7%) | $3.59 B(+4.7%) |
| Dec 2011 | $3.43 B(-17.8%) | $1.16 B(+9283.3%) | $3.43 B(+50.9%) |
| Sept 2011 | - | $12.34 M(-99.2%) | $2.28 B(+0.5%) |
| June 2011 | - | $1.54 B(+112.9%) | $2.26 B(+212.9%) |
| Mar 2011 | - | $723.20 M | $723.20 M |
| Dec 2010 | $4.18 B(-9.9%) | - | - |
| Dec 2009 | $4.64 B | - | - |
FAQ
- What is AbbVie annual net profit?
- What is the all time high annual net income for AbbVie?
- What is AbbVie annual net income year-on-year change?
- What is AbbVie quarterly net profit?
- What is the all time high quarterly net income for AbbVie?
- What is AbbVie quarterly net income year-on-year change?
- What is AbbVie TTM net profit?
- What is the all time high TTM net income for AbbVie?
- What is AbbVie TTM net income year-on-year change?
What is AbbVie annual net profit?
The current annual net income of ABBV is $4.86 B
What is the all time high annual net income for AbbVie?
AbbVie all-time high annual net profit is $11.84 B
What is AbbVie annual net income year-on-year change?
Over the past year, ABBV annual net profit has changed by -$6.97 B (-58.91%)
What is AbbVie quarterly net profit?
The current quarterly net income of ABBV is $1.56 B
What is the all time high quarterly net income for AbbVie?
AbbVie all-time high quarterly net profit is $4.49 B
What is AbbVie quarterly net income year-on-year change?
Over the past year, ABBV quarterly net profit has changed by -$217.00 M (-12.20%)
What is AbbVie TTM net profit?
The current TTM net income of ABBV is $5.12 B
What is the all time high TTM net income for AbbVie?
AbbVie all-time high TTM net profit is $13.41 B
What is AbbVie TTM net income year-on-year change?
Over the past year, ABBV TTM net profit has changed by -$1.39 B (-21.37%)